A detailed mechanisticstudy concerning selective toxicity againstcancer cell lines over normal cells (IMR90 cells in this study) suggeststhe time-dependent toxicity of TPH-ACs against cancer cells over normalcells, which could be one of the future strategies in cancer chemotherapyand in controlling toxicity of anticancer drugs. The gene discussed is TPH1; the disease is cancer.